First-Year Experiences with the Interagency Guidelines for Drug Donations
(2000; 51 pages)
Índice de contenido
Ver el documentoAcknowledgements
Ver el documentoExecutive summary
Abrir esta carpeta y ver su contenido1. Introduction
Abrir esta carpeta y ver su contenido2. Sources of information and study methodology
Abrir esta carpeta y ver su contenido3. Dissemination and uptake of the Guidelines
Cerrar esta carpeta4. Basic characteristics of drug donations
Ver el documentoMagnitude of donations made in the past 12 months
Ver el documentoCost basis of donation value
Ver el documentoPercentage of donations made for emergencies
Ver el documentoPercentage of donations based on specific requests
Abrir esta carpeta y ver su contenido5. Practical benefits as a result of the Guidelines
Ver el documento6. Drug donations which were hampered, delayed or cancelled
Abrir esta carpeta y ver su contenido7. Experiences and opinions regarding the 12-month shelf-life requirement
Abrir esta carpeta y ver su contenido8. Other suggestions to improve the Guidelines
Abrir esta carpeta y ver su contenido9. How could donation practice be further improved?
Ver el documento10. Summary of recommendations
Ver el documento11. Postscript
Ver el documentoReferences
 

Cost basis of donation value

There was no consistency of method for calculating the value of donations. Some respondents cited more than one method, depending on the nature of the donation. Overall, wholesale cost basis calculation appears to be the commonest (28%), followed by generic cost basis (20%), retail cost basis (9%) and other methods (3%).

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013